GPC Biotech AG (ADR) (NASDAQOTH:GPCBY.DL)
CAPS Rating:
The Company is publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked GPCBY.DL yet. Tell us why you think GPCBY.DL will outperform or underperform the market.
RSS Headlines
Fool UK
